160 related articles for article (PubMed ID: 11132728)
21. Repair of furocoumarin-plus-UVA-induced damage and mutagenic consequences in eukaryotic cells.
Averbeck D; Dardalhon M; Magana-Schwencke N
J Photochem Photobiol B; 1990 Jun; 6(1-2):221-36. PubMed ID: 2121936
[TBL] [Abstract][Full Text] [Related]
22. The mechanisms of action of phototherapy in the treatment of the most common dermatoses.
Bulat V; Situm M; Dediol I; Ljubicić I; Bradić L
Coll Antropol; 2011 Sep; 35 Suppl 2():147-51. PubMed ID: 22220423
[TBL] [Abstract][Full Text] [Related]
23. Psoralen photochemotherapy for vitiligo.
Grimes PE
Clin Dermatol; 1997; 15(6):921-6. PubMed ID: 9404695
[No Abstract] [Full Text] [Related]
24. Psoralenamines. 3. Synthesis, pharmacological behavior, and DNA binding of 5-(aminomethyl)-8-methoxy-, 5-[[(3-aminopropyl)oxy]methyl]-, and 8-[(3-aminopropyl)oxy]psoralen derivatives.
Hansen JB; Bjerring P; Buchardt O; Ebbesen P; Kanstrup A; Karup G; Knudsen PH; Nielsen PE; Nordén B; Ygge B
J Med Chem; 1985 Aug; 28(8):1001-10. PubMed ID: 4020822
[TBL] [Abstract][Full Text] [Related]
25. [Problems posed by the therapeutic use of photosensitizers in dermatology].
Beani JC; Amblard P; Reymond JL
Biochimie; 1986 Jun; 68(6):905-12. PubMed ID: 2944547
[TBL] [Abstract][Full Text] [Related]
26. Environmental UVA radiation and eye protection during PUVA therapy.
Morison WL; Strickland PT
J Am Acad Dermatol; 1983 Oct; 9(4):522-5. PubMed ID: 6630614
[TBL] [Abstract][Full Text] [Related]
27. The application of antioxidants in investigations and optimization of photochemotherapy.
Potapenko AY; Kyagova AA
Membr Cell Biol; 1998; 12(2):269-78. PubMed ID: 9879549
[TBL] [Abstract][Full Text] [Related]
28. Psoralen photochemotherapy.
Gupta AK; Anderson TF
J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):703-34. PubMed ID: 3316316
[TBL] [Abstract][Full Text] [Related]
29. Activation of keratinocytes with psoralen plus UVA radiation induces the release of soluble factors that suppress delayed and contact hypersensitivity.
Aubin F; Kripke ML; Ullrich SE
J Invest Dermatol; 1991 Dec; 97(6):995-1000. PubMed ID: 1748824
[TBL] [Abstract][Full Text] [Related]
30. Effects of a new psoralen, 5-geranoxypsoralen, plus UVA radiation on murine ATPase positive Langerhans cells.
Aubin F; Humbert P; Agache P
J Dermatol Sci; 1994 Jun; 7(3):176-84. PubMed ID: 7918236
[TBL] [Abstract][Full Text] [Related]
31. DNA repair synthesis in human skin exposed to ultraviolet radiation used in PUVA (psoralen and UV-A) therapy for psoriasis.
Bishop SC
Br J Dermatol; 1979 Oct; 101(4):399-405. PubMed ID: 508605
[TBL] [Abstract][Full Text] [Related]
32. Squamous cell carcinoma. Occurrence in mycosis fungoides treated with psoralens plus long-wave ultraviolet radiation.
Verdich J
Arch Dermatol; 1979 Nov; 115(11):1338-9. PubMed ID: 507889
[TBL] [Abstract][Full Text] [Related]
33. Photosensitization of mammalian cells by psoralens and porphyrins.
Moreno G
Biochimie; 1986 Jun; 68(6):869-73. PubMed ID: 3092880
[TBL] [Abstract][Full Text] [Related]
34. Cellular and molecular mechanisms in photochemical sensitization: studies on the mechanism of action of psoralens.
Laskin JD
Food Chem Toxicol; 1994 Feb; 32(2):119-27. PubMed ID: 8132171
[TBL] [Abstract][Full Text] [Related]
35. Comparison of psoralen-UVB and psoralen-UVA photochemotherapy in the treatment of psoriasis.
de Berker DA; Sakuntabhai A; Diffey BL; Matthews JN; Farr PM
J Am Acad Dermatol; 1997 Apr; 36(4):577-81. PubMed ID: 9092744
[TBL] [Abstract][Full Text] [Related]
36. Effects of psoriasis and psoralen exposure on the somatic mutation landscape of the skin.
Olafsson S; Rodriguez E; Lawson ARJ; Abascal F; Huber AR; Suembuel M; Jones PH; Gerdes S; Martincorena I; Weidinger S; Campbell PJ; Anderson CA
Nat Genet; 2023 Nov; 55(11):1892-1900. PubMed ID: 37884686
[TBL] [Abstract][Full Text] [Related]
37. Clinical pharmacokinetics of methoxsalen and other psoralens.
de Wolff FA; Thomas TV
Clin Pharmacokinet; 1986; 11(1):62-75. PubMed ID: 3512141
[TBL] [Abstract][Full Text] [Related]
38. Biopharmaceutics, pharmacokinetics and pharmacology of psoralens.
Stolk LM; Siddiqui AH
Gen Pharmacol; 1988; 19(5):649-53. PubMed ID: 3063592
[TBL] [Abstract][Full Text] [Related]
39. Effect of psoralen plus ultraviolet A radiation on in vivo growth of melanoma cells.
Aubin F; Donawho CK; Kripke ML
Cancer Res; 1991 Nov; 51(21):5893-7. PubMed ID: 1933857
[TBL] [Abstract][Full Text] [Related]
40. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
Sakuntabhai A; Farr PM; Diffey BL
Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
